Centene Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Centene ha aumentado sus beneficios a una tasa media anual de 14.6%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 7.1% anual. Los ingresos han ido creciendo a una tasa media de 17.6% al año. La rentabilidad financiera de Centene es de 10.4%, y sus márgenes netos son de 1.9%.
Información clave
15.1%
Tasa de crecimiento de los beneficios
9.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare | 8.5% |
| Tasa de crecimiento de los ingresos | 16.1% |
| Rentabilidad financiera | 10.1% |
| Margen neto | 1.9% |
| Próxima actualización de resultados | 26 Jul 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
May 14
These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Apr 26Centene Corporation Still An Opportunity With An A-Grade Valuation
Mar 31If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Mar 15Market Still Lacking Some Conviction On Centene Corporation (NYSE:CNC)
Feb 08Centene: Stay Defensive Amid Economic Uncertainty With This Low-Beta Bargain
Jan 22Is Centene (NYSE:CNC) Using Too Much Debt?
Jan 21Centene: Overlooked Healthcare Giant
Nov 21Does Centene (NYSE:CNC) Deserve A Spot On Your Watchlist?
Nov 10Centene: Solid Performance With Positive Outlook, But Limited Upside Potential
Oct 26These 4 Measures Indicate That Centene (NYSE:CNC) Is Using Debt Reasonably Well
Oct 22Decoding Centene: Why I Think It's Undervalued
Oct 10If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 31Centene: Results Impress But Buyers Aren't Swarming Yet
Jul 27Centene (NYSE:CNC) Has A Pretty Healthy Balance Sheet
Jul 12Centene (NYSE:CNC) Seems To Use Debt Quite Sensibly
Apr 10Centene Non-GAAP EPS of $0.86 beats by $0.02, revenue of $35.56B beats by $190M
Feb 07With EPS Growth And More, Centene (NYSE:CNC) Makes An Interesting Case
Jan 27Centene (NYSE:CNC) Seems To Use Debt Rather Sparingly
Dec 27Centene: Once Again, With Quality, Now A 'Buy'
Dec 23Centene appoints new leadership; Ken Fasola President of Centene, Dave Thomas CEO of Medicaid
Dec 14An Intrinsic Calculation For Centene Corporation (NYSE:CNC) Suggests It's 50% Undervalued
Nov 11Is Now The Time To Put Centene (NYSE:CNC) On Your Watchlist?
Oct 26Centene Q3 2022 Earnings Preview
Oct 24Centene: Future Growth Will Exceed Market Expectations
Oct 14Centene: A Chaos Stock
Sep 28Does Centene (NYSE:CNC) Have A Healthy Balance Sheet?
Sep 20Centene falls 7%, most since April 2021, on surging volume
Sep 14If EPS Growth Is Important To You, Centene (NYSE:CNC) Presents An Opportunity
Jul 28Centene Q2 2022 Earnings Preview
Jul 25Centene Keeps Overdelivering - But Is Expensive
Jul 11Is Centene (NYSE:CNC) Using Too Much Debt?
Jun 16Centene: Solid Q122 Earnings For Health Insurer Helps Make Buy/Hold Case
Apr 28Centene Has Overdelivered - It Is Time For A 'Hold'
Mar 24We Think Centene (NYSE:CNC) Can Stay On Top Of Its Debt
Mar 14Centene: Finally Gets Respect And Is Poised To Profit
Dec 31Desglose de ingresos y gastos
Cómo gana y gasta dinero Centene. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 24 | 142,800 | 2,735 | 12,573 | 0 |
| 31 Dec 23 | 141,266 | 2,702 | 12,407 | 0 |
| 30 Sep 23 | 139,285 | 2,444 | 12,130 | 0 |
| 30 Jun 23 | 138,032 | 2,713 | 11,934 | 0 |
| 31 Mar 23 | 136,941 | 1,483 | 11,704 | 0 |
| 31 Dec 22 | 135,999 | 1,202 | 11,366 | 0 |
| 30 Sep 22 | 132,756 | 2,014 | 10,892 | 0 |
| 30 Jun 22 | 129,228 | 1,860 | 10,562 | 0 |
| 31 Mar 22 | 124,181 | 1,497 | 9,888 | 0 |
| 31 Dec 21 | 118,573 | 1,347 | 9,376 | 0 |
| 30 Sep 21 | 114,130 | 736 | 9,657 | 0 |
| 30 Jun 21 | 111,284 | 720 | 9,995 | 0 |
| 31 Mar 21 | 108,158 | 2,461 | 10,461 | 0 |
| 31 Dec 20 | 104,280 | 1,808 | 10,276 | 0 |
| 30 Sep 20 | 95,764 | 2,029 | 9,529 | 0 |
| 30 Jun 20 | 86,523 | 1,556 | 8,301 | 0 |
| 31 Mar 20 | 78,105 | 845 | 7,290 | 0 |
| 31 Dec 19 | 70,807 | 1,321 | 6,448 | 0 |
| 30 Sep 19 | 68,385 | 1,353 | 6,472 | 0 |
| 30 Jun 19 | 65,507 | 1,277 | 6,591 | 0 |
| 31 Mar 19 | 61,028 | 1,082 | 6,457 | 0 |
| 31 Dec 18 | 56,688 | 900 | 6,331 | 0 |
| 30 Sep 18 | 52,618 | 889 | 5,795 | 0 |
| 30 Jun 18 | 48,655 | 1,075 | 5,105 | 0 |
| 31 Mar 18 | 47,201 | 1,029 | 4,797 | 0 |
| 31 Dec 17 | 45,810 | 828 | 4,370 | 0 |
| 30 Sep 17 | 44,870 | 853 | 4,267 | 0 |
| 30 Jun 17 | 43,646 | 796 | 4,303 | 0 |
| 31 Mar 17 | 42,468 | 713 | 4,246 | 0 |
| 31 Dec 16 | 37,693 | 562 | 3,900 | 0 |
| 30 Sep 16 | 32,839 | 416 | 3,284 | 0 |
| 30 Jun 16 | 28,062 | 360 | 2,719 | 0 |
| 31 Mar 16 | 22,948 | 277 | 2,152 | 0 |
| 31 Dec 15 | 21,292 | 356 | 1,990 | 0 |
| 30 Sep 15 | 19,854 | 350 | 1,827 | 0 |
| 30 Jun 15 | 18,548 | 339 | 1,699 | 0 |
| 31 Mar 15 | 17,102 | 298 | 1,564 | 0 |
| 31 Dec 14 | 15,689 | 268 | 1,424 | 0 |
| 30 Sep 14 | 14,134 | 210 | 1,300 | 0 |
| 30 Jun 14 | 12,700 | 179 | 1,183 | 0 |
| 31 Mar 14 | 11,475 | 172 | 1,055 | 0 |
| 31 Dec 13 | 10,544 | 161 | 931 | 0 |
| 30 Sep 13 | 9,427 | 209 | 841 | 0 |
| 30 Jun 13 | 8,932 | 162 | 773 | 0 |
Ingresos de calidad: CNC tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (1.9%) de CNC son superiores a los del año pasado (0.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de CNC han crecido un 14.6% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de CNC en el último año (124.8%) supera su media de 5 años (14.6% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de CNC en el último año (124.8%) superó al de la industria Healthcare 7.3%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de CNC (10.4%) se considera baja.